FDA Should Assume Authority Over Human Cloning

Law360, New York (January 13, 2014, 6:15 PM EST) -- Everywhere you turn today the promise and potential of stem cell research is apparent. Recently, for example, researchers at the Oregon Health & Science University reported that they had successfully derived six pluripotent, embryonic stem cell lines created by somatic cell nuclear transfer ("SCNT").[1] While questions have been raised about errors in the report over duplication of figures, the experiment has nevertheless been acclaimed as a historic achievement with important clinical implications.[2] Indeed, the genetic identity of these stem cells to the patient’s own cells dramatically...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.